parallel randomized trial
S002970
Design
Conduct and analysis
Arms
| Arm | Treatment | Background | Randomized | Analyzed | Completed treatment |
|---|---|---|---|---|---|
| A1 | Lifestyle intervention (randomized arm) Lifestyle intervention | lifestyle: standard | 22 | 22 | |
| A2 | Liraglutide 1.2 mg subcutaneous once daily Liraglutide | lifestyle: not reported | 17 | 17 |
Baseline characteristics
As printed in the trial reports or registry, per arm or for the whole trial.
| Characteristic | Statistic | Lifestyle intervention (randomized arm) A1 | Liraglutide 1.2 mg subcutaneous once daily A2 |
|---|---|---|---|
| age | mean (years) | 48.91 | 44.92 |
| age | sd (years) | 10.12 | 14.69 |
| bmi | mean (kg/m2) | 26.21 | 26.84 |
| bmi | sd (kg/m2) | 4.33 | 2.47 |
| female | n | 15 | 11 |
| female | percent | 68.18 | 64.71 |
| hba1c | mean (percent) | 5.91 | 5.98 |
| hba1c | sd (percent) | 0.33 | 0.42 |
| sbp | mean (mmHg) | 69.47 | 67.33 |
| sbp | sd (mmHg) | 11.13 | 10.57 |
| waist | mean (cm) | 87.12 | 86.52 |
| waist | sd (cm) | 5.74 | 4.98 |
Analyses this trial contributes to
- NauseaOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- NauseaOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- VomitingOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- VomitingOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- DiarrheaOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- DiarrheaOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- ConstipationOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- ConstipationOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
Results
12 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
Systolic blood pressure change (4 lines; O05)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 26.07 | A1 | change | -0.25 mmHg | 22 | not stated; other; R0008860:Table I | ||
| 26.07 | A1 | final | 69.22 mmHg | 11.64 | 22 | not stated; other; R0008860:Table I | |
| 26.07 | A2 | change | -0.31 mmHg | 17 | not stated; other; R0008860:Table I | ||
| 26.07 | A2 | final | 67.02 mmHg | 11.16 | 17 | not stated; other; R0008860:Table I |
Nausea (2 lines; O27A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 1 / 22 | not stated; randomized; R0008860:Supplementary Table SI | ||||
| A2 | events | 4 / 17 | not stated; randomized; R0008860:Supplementary Table SI |
Vomiting (2 lines; O27B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 22 | not stated; randomized; R0008860:Supplementary Table SI | ||||
| A2 | events | 0 / 17 | not stated; randomized; R0008860:Supplementary Table SI |
Diarrhea (2 lines; O27C)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 1 / 22 | not stated; randomized; R0008860:Supplementary Table SI | ||||
| A2 | events | 2 / 17 | not stated; randomized; R0008860:Supplementary Table SI |
Constipation (2 lines; O27D)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 22 | not stated; randomized; R0008860:Supplementary Table SI | ||||
| A2 | events | 0 / 17 | not stated; randomized; R0008860:Supplementary Table SI |